ALS, Denali
Hosted on MSN15m
Baird Initiates Coverage of Denali Therapeutics (DNLI) with Outperform RecommendationFintel reports that on January 7, 2025, Baird initiated coverage of Denali Therapeutics (NasdaqGS:DNLI) with a Outperform ...
Denali's DNL343 missed efficacy goals in the HEALEY ALS trial but was well-tolerated. Analysts await detailed biomarker data ...
Denali’s failure on Monday continues biopharma’s losing streak against amyotrophic lateral sclerosis. PTC Therapeutics and ...
Nvidia stock rises after the artificial-intelligence chip maker unveils its next generation gaming graphic cards, while ...
Denali Therapeutics has reported that its Phase II/III HEALEY ALS Platform trial of DNL343 for ALS failed to meet its primary endpoint.
New research on the Denali Fault reveals three geologic sites were once united in a suture zone, marking the integration of ...
Fort Smith area plaintiffs have not shown they suffered physical harm from an intermittent but widespread offensive smell in ...
Denali Bancorporation, Inc., the parent company of Denali State Bank, announced a $0.05 increase in its quarterly cash ...
Mashpee Wampanoag educator Kitty Hendricks-Miller (Nanaweetah), consults on PBS 'Molly of Denali' as Cape-based tribe debuts ...
Should a name chosen by someone in 1897 trump a name used by Koyukon people for thousands of years just because they didn’t publish it in a newspaper before he did?
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback